Ms. Burleson is a Certified Public Accountant with more than 25 years of progressive experience in advising and developing key business support operations across a variety of industries, including healthcare, pharmaceutical, and biomedical R&D. Ms. Burleson is the Chief Operating Officer of Translational Genomics Research Institute and the President of TGen Health Ventures, where she has incubated 15 early-stage technologies through commercialization. Previously, Ms. Burleson served as Chief Financial Officer at Lovelace Medical Foundation, President at Lovelace Scientific Resources, and at KPMG where she served primarily in Audit and Advisory Services. Ms. Burleson earned Advanced Finance Certification from The Wharton School of the University of Pennsylvania, a B.B.A in Accounting, and a Master of Business Administration from the University of New Mexico.